For several decades, Permira-backed Neuraxpharm has been a pioneer in the pharmaceutical industry, developing and supplying life-changing Central Nervous System medications. Here, Florian Kreuzer, Head of DACH at Permira, and Dr. Jorg Thomas Dierks, CEO of Neuraxpharm, comment on how Permira's support has driven Neuraxpharm’s international growth and global authority.
16 Jun 2023